Skip to main navigation
Skip to search
Skip to main content
University of Luebeck Home
English
Deutsch
Home
Research Units
Experts
Publications
Projects
Datasets
Prizes
Spin-Offs
Activities
Media
Search by expertise, name or affiliation
Multimodale Therapie des hepatozellulären Karzinoms
Translated title of the contribution
:
Multimodal treatment of hepatocellular carcinoma
M. M. Kirstein
*
, T. C. Wirth
*
Corresponding author for this work
Clinic of Internal Medicine I
Hannover Medical School
6
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Multimodal treatment of hepatocellular carcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Ablation Therapy
20%
Cabozantinib
20%
Clinical Study
20%
Combination Therapy
20%
Cooperation
20%
Hepatocellular Carcinoma
100%
Immune Checkpoint Inhibitor
20%
Immunotherapy
20%
Lenvatinib
20%
Liver Transplantation
20%
Local Excision
20%
Microwave Thermotherapy
20%
Monotherapy
40%
Overall Survival
20%
Phosphotransferase Inhibitor
20%
Radiofrequency Ablation
20%
Ramucirumab
20%
Regorafenib
20%
Sorafenib
40%
Systemic Therapy
40%
Transcatheter Arterial Chemoembolization
20%
Tyrosine-Kinase Inhibitor
20%
Vasculotropin
20%
Pharmacology, Toxicology and Pharmaceutical Science
Cabozantinib
20%
Clinical Study
20%
Combination Therapy
20%
Immune Checkpoint Inhibitor
20%
Lenvatinib
20%
Liver Cell Carcinoma
100%
Monotherapy
40%
Overall Survival
20%
Phosphotransferase Inhibitor
20%
Protein Tyrosine Kinase Inhibitor
20%
Ramucirumab
20%
Regorafenib
20%
Sorafenib
40%
Systemic Treatment
20%
Vasculotropin
20%
Vasculotropin Receptor
20%